Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with sickle cell disease (SCD), according to new research published in Blood ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Hydroxyurea conferred benefit to children and adults with hemoglobin SC disease, according to study ...

Advances in sickle cell therapies, including gene editing, offer hope—but racial disparities, cost, and access barriers remain major challenges. Racial and ethnic disparities in health care persist in ...